Gastrointestinal Cancer
From the Journals
Potential new standard of care for biliary tract cancer
Biliary tract cancers are a relatively rare and heterogeneous group of cancers, but global incidence is rising.
Latest News
Novel treatment shows early promise for gastric cancer
The AK104 antibody treatment combined with chemotherapy demonstrated a manageable safety profile.
Latest News
Endoscopic mucosal resection valuable for cancer diagnosis
Endoscopic mucosal resection offers advantages over endoscopic submucosal dissection for most Barrett’s esophagus.
Latest News
Decades of research fail to resolve disparities in gastrointestinal cancer care
Women, Blacks, and Latinos still dying from gastroesophageal cancer at higher rates than men and Whites in general.
Latest News
Can immunotherapy replace surgery for stomach cancer?
The complete pathologic response rate to neoadjuvant nivolumab/ipilimumab was 59%.
Latest News
Oxaliplatin add-on not recommended for elderly with colon cancer
A study of elderly patients with metastatic colon cancer shows no benefit and an increased neuropathy risk.
Latest News
Medicare NCDs hinder access to cancer biomarker testing for minorities
Failure to expand Medicare benefits widens disparities in biomarker testing. Study authors say additional efforts are needed to ensure equitable...
Latest News
Abraxane still in short supply for cancer patients
Allotments for this chemotherapy drug are waning but patients are willing to travel for treatment.
From the Journals
Margin marking of polyps before EMR cuts recurrence: Study
After 6 months, EMR-MM led to a lower recurrence rate compared with the historical control group with traditional EMR.
From the Journals
GERD: Upper endoscopy may reduce GI cancer mortality
The relatively high incidence of upper GI cancer among patients with GERD suggests benefit from even one endoscopy, according to the investigators...
Latest News
Triple therapy for HER2-positive gastric cancer shrinks tumors for most in study
Immune checkpoint inhibition plus trastuzumab and chemotherapy produced a striking response rate for patients with aggressive gastric cancer.